Growth factor regulation of the amylase promoter in a differentiating salivary acinar cell line.
Salivary glands contain two major epithelial cell types: acinar cells which produce the primary salivary secretion, including amylase, and ductal cells which reabsorb electrolytes but also secrete kallikrein. Here we investigated salivary acinar cell differentiation in vitro using the activity of the salivary amylase and tissue kallikrein promoters as markers of acinar cell and ductal cell differentiation, respectively. Each of the promoter sequences was cloned into a replication-deficient adenoviral vector containing the luciferase reporter gene. Previous studies showed that a human submandibular gland cell line (HSG) differentiated into acinar cells when cultured on a reconstituted basement membrane matrix (Matrigel). The luciferase activity of the amylase promoter vector (AdAMY-luc) was low in HSG cells cultured on plastic, where they grow as an epithelial monolayer. The promoter activity increased approximately tenfold when HSG cells were cultured on Matrigel and developed an acinar phenotype. Under the same conditions, the luciferase activity of the kallikrein promoter (AdKALL-luc) was not induced. Because HSG cells demonstrate acinar cell morphology, but not amylase gene expression, when cultured on laminin-1, certain soluble components of Matrigel were tested for their ability to induce the amylase promoter during in vitro differentiation of acinar cells. We find that epidermal growth factor (EGF) and transforming growth factor-alpha (TGF-alpha), which are present in the basement membrane, and hepatocyte growth factor (HGF) increase activity of the amylase promoter. Other basement membrane-derived growth factors such as TGF-beta, basic fibroblast growth factor (bFGF), and platelet-derived growth factor (PGDF), as well as tumor necrosis factor (TNF-alpha), keratinocyte growth factor (KGH), nerve growth factor (NGF) and interferon gamma (IFN-gamma) were inactive. This system will be further exploited to study the mechanisms by which extracellular matrix molecules and growth factors regulate salivary acinar cell differentiation.
Zheng
C
C
Gene Therapy and Therapeutics Branch, National Institute of Dental Research, National Institutes of Health, Bethesda, Maryland 20892-1190, USA.
Hoffman
M P
MP
McMillan
T
T
Kleinman
H K
HK
O'Connell
B C
BC
D000681:Amylases / Q000096:biosynthesis / Q000235:genetics*; D000818:Animals; D015415:Biomarkers; D018929:Cell Culture Techniques / Q000295:instrumentation; D002454:Cell Differentiation / Q000187:drug effects; D002478:Cells, Cultured; D003094:Collagen; D004338:Drug Combinations; D004790:Enzyme Induction / Q000187:drug effects; D004815:Epidermal Growth Factor / Q000494:pharmacology; D004847:Epithelial Cells / Q000166:cytology / Q000187:drug effects / Q000201:enzymology; D017930:Genes, Reporter; D006133:Growth Substances / Q000494:pharmacology*; D017228:Hepatocyte Growth Factor / Q000494:pharmacology; D006801:Humans; D007610:Kallikreins / Q000096:biosynthesis / Q000235:genetics; D007797:Laminin; D008156:Luciferases / Q000096:biosynthesis; D010969:Plastics; D011401:Promoter Regions, Genetic; D011509:Proteoglycans; D051381:Rats; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis; D013363:Submandibular Gland / Q000166:cytology* / Q000187:drug effects / Q000201:enzymology; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
D015415:Biomarkers; D004338:Drug Combinations; D006133:Growth Substances; D007797:Laminin; D010969:Plastics; D011509:Proteoglycans; D011993:Recombinant Fusion Proteins; D014409:Tumor Necrosis Factor-alpha; C059485:matrigel; D004815:Epidermal Growth Factor; D017228:Hepatocyte Growth Factor; D003094:Collagen; D008156:Luciferases; D000681:Amylases; D007610:Kallikreins